Literature DB >> 32480407

Associations of Per- and Polyfluoroalkyl Substances (PFAS) With Glucose Tolerance During Pregnancy in Project Viva.

Emma V Preston1, Sheryl L Rifas-Shiman2, Marie-France Hivert2,3, Ami R Zota4, Sharon K Sagiv5, Antonia M Calafat6, Emily Oken2, Tamarra James-Todd1,7.   

Abstract

CONTEXT: Per- and polyfluoroalkyl substances (PFAS) exposure may alter glucose homeostasis. Research on PFAS exposure and glucose tolerance during pregnancy is limited.
OBJECTIVE: The objective of this work is to estimate associations between first-trimester plasma PFAS concentrations and glucose tolerance assessed in late second pregnancy trimester. DESIGN, SETTING, PARTICIPANTS, AND MAIN OUTCOME MEASURES: Pregnant women (n = 1540) enrolled in Project Viva in 1999 to 2002 provided first-trimester plasma samples analyzed for 8 PFAS. At approximately 28 weeks' gestation, women completed 1-hour nonfasting, 50-g oral glucose challenge tests (GCTs); if abnormal, women completed subsequent 3-hour oral glucose tolerance tests (OGTTs) to screen for gestational diabetes mellitus (GDM). We assessed both continuous GCT glucose levels and 4 categories of glucose tolerance (normal glycemia [reference], isolated hyperglycemia, impaired glucose tolerance, GDM). We used multinomial logistic regression to estimate associations of PFAS with glucose tolerance categories. We used multivariable linear regression and Bayesian kernel machine regression (BKMR) to assess individual and joint effects of PFAS on continuous GCT glucose levels, respectively. We evaluated effect modification by maternal age and race/ethnicity.
RESULTS: PFAS were not associated with glucose tolerance categories. In BKMR analyses, we observed a positive association between ln-perfluorooctane sulfonate (PFOS) and glucose levels (Δ25th to 75th percentile: 6.2 mg/dL, 95% CI, 1.1-11.3) and an inverse-U shaped association between 2-(N-perfluorooctane sulfonamide) acetate and glucose levels. Individual linear regression results were similar. We found suggestive evidence that associations varied by age and racial/ethnic group.
CONCLUSION: Certain PFAS may alter glucose homeostasis during pregnancy, but may not be associated with overt GDM. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  PFAS; gestational diabetes; impaired glucose tolerance; metabolic disruptors; pregnancy glucose

Mesh:

Substances:

Year:  2020        PMID: 32480407      PMCID: PMC7320827          DOI: 10.1210/clinem/dgaa328

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  57 in total

Review 1.  Human exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water: A review of the recent scientific literature.

Authors:  José L Domingo; Martí Nadal
Journal:  Environ Res       Date:  2019-08-12       Impact factor: 6.498

2.  Gestational diabetes and offspring birth size at elevated environmental pollutant exposures.

Authors:  Damaskini Valvi; Youssef Oulhote; Pal Weihe; Christine Dalgård; Kristian S Bjerve; Ulrike Steuerwald; Philippe Grandjean
Journal:  Environ Int       Date:  2017-07-25       Impact factor: 9.621

Review 3.  Racial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians.

Authors:  Brooke R Hasson; Caroline Apovian; Nawfal Istfan
Journal:  Curr Obes Rep       Date:  2015-06

4.  A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes.

Authors:  Cuilin Zhang; Rajeshwari Sundaram; José Maisog; Antonia M Calafat; Dana Boyd Barr; Germaine M Buck Louis
Journal:  Fertil Steril       Date:  2014-10-22       Impact factor: 7.329

Review 5.  Effects of ageing and senescence on pancreatic β-cell function.

Authors:  A Helman; D Avrahami; A Klochendler; B Glaser; K H Kaestner; I Ben-Porath; Y Dor
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

Review 6.  Perfluoroalkyl acids: a review of monitoring and toxicological findings.

Authors:  Christopher Lau; Katherine Anitole; Colette Hodes; David Lai; Andrea Pfahles-Hutchens; Jennifer Seed
Journal:  Toxicol Sci       Date:  2007-05-22       Impact factor: 4.849

7.  Hyperglycemia and adverse pregnancy outcomes.

Authors:  Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

8.  Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David Williams
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

9.  Statistical Approaches for Assessing Health Effects of Environmental Chemical Mixtures in Epidemiology: Lessons from an Innovative Workshop.

Authors:  Kyla W Taylor; Bonnie R Joubert; Joe M Braun; Caroline Dilworth; Chris Gennings; Russ Hauser; Jerry J Heindel; Cynthia V Rider; Thomas F Webster; Danielle J Carlin
Journal:  Environ Health Perspect       Date:  2016-12-01       Impact factor: 9.031

Review 10.  The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis.

Authors:  Samira Behboudi-Gandevani; Mina Amiri; Razieh Bidhendi Yarandi; Fahimeh Ramezani Tehrani
Journal:  Diabetol Metab Syndr       Date:  2019-02-01       Impact factor: 3.320

View more
  7 in total

1.  Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Dandan Yan; Yang Jiao; Honglin Yan; Tian Liu; Hong Yan; Jingping Yuan
Journal:  Environ Health       Date:  2022-05-16       Impact factor: 7.123

2.  Persistent organic pollutants and maternal glycemic outcomes in a diverse pregnancy cohort of overweight women.

Authors:  Suril S Mehta; Tamarra James-Todd; Katie M Applebaum; Andrea Bellavia; Kimberly Coleman-Phox; Nancy Adler; Barbara Laraia; Elissa Epel; Emily Parry; Miaomiao Wang; June-Soo Park; Ami R Zota
Journal:  Environ Res       Date:  2020-12-02       Impact factor: 6.498

Review 3.  A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus.

Authors:  Rahel L Birru; Hai-Wei Liang; Fouzia Farooq; Megha Bedi; Maisa Feghali; Catherine L Haggerty; Dara D Mendez; Janet M Catov; Carla A Ng; Jennifer J Adibi
Journal:  Environ Health       Date:  2021-05-22       Impact factor: 7.123

Review 4.  Associations between Exposures to Perfluoroalkyl Substances and Diabetes, Hyperglycemia, or Insulin Resistance: A Scoping Review.

Authors:  Rachel Margolis; Karilyn E Sant
Journal:  J Xenobiot       Date:  2021-09-14

Review 5.  Per- and Polyfluoroalkyl Substances (PFAS) in Integrated Crop-Livestock Systems: Environmental Exposure and Human Health Risks.

Authors:  Gaurav Jha; Vanaja Kankarla; Everald McLennon; Suman Pal; Debjani Sihi; Biswanath Dari; Dawson Diaz; Mallika Nocco
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

Review 6.  Praegnatio Perturbatio-Impact of Endocrine-Disrupting Chemicals.

Authors:  Vasantha Padmanabhan; Wenhui Song; Muraly Puttabyatappa
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

Review 7.  Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects.

Authors:  Elsi Haverinen; Mariana F Fernandez; Vicente Mustieles; Hanna Tolonen
Journal:  Int J Environ Res Public Health       Date:  2021-12-10       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.